Clinical-Stage Platforms
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 TMO | Thermo Fisher Scientific, Inc. | $178.3b | $467.88 | -0.4% | 2.3M |
 A | Agilent Technologies Inc. | $31.7b | $115.62 | +0.1% | 1.5M |
 WAT | Waters Corp | $28.8b | $304.93 | -1.6% | 1.2M |
 IQV | IQVIA Holdings Inc. | $27.9b | $163.84 | +1.0% | 982.4K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $19.9b | $49.65 | +0.5% | 4.1M |
 WST | West Pharmaceutical Services, Inc. | $17.7b | $302.20 | -1.3% | 1.1M |
 MEDP | Medpace Holdings, Inc. Common Stock | $13.1b | $421.61 | +2.7% | 618.2K |
 RVTY | Revvity, Inc. | $9.5b | $86.80 | +0.0% | 1.0M |
 TECH | Bio-Techne Corp. | $8.1b | $55.12 | +1.7% | 1.5M |
 QGEN | QIAGEN N.V. | $8.1b | $36.60 | -4.7% | 1.5M |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $8.1b | $292.34 | -2.4% | 76 |
 ICLR | Icon Plc | $8.0b | $103.14 | +1.0% | 3.4M |
 CRL | Charles River Laboratories International, Inc. | $7.9b | $171.23 | +0.8% | 750.6K |
 HALO | Halozyme Therapeutics, Inc. | $7.4b | $64.49 | -1.3% | 1.3M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.5b | $86.68 | +2.1% | 513.6K |
 RGEN | Repligen Corp | $6.3b | $118.35 | +0.6% | 907.8K |
 CGON | CG Oncology, Inc. Common stock | $5.4b | $66.87 | -2.6% | 758.0K |
 CELC | Celcuity Inc. Common Stock | $5.2b | $125.75 | +3.9% | 995.4K |
 BRKR | Bruker Corporation | $5.2b | $36.52 | -0.1% | 1.7M |
 AVTR | Avantor, Inc. | $5.1b | $8.04 | +1.8% | 7.4M |
 LGND | Ligand Pharmaceuticals Inc. | $3.8b | $242.19 | +4.7% | 281.0K |
 TWST | Twist Bioscience Corporation Common Stock | $2.7b | $61.06 | +0.2% | 1.1M |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 MANE | Veradermics, Incorporated | $2.1b | $98.94 | +45.8% | 3.4M |
 KOD | Kodiak Sciences Inc Common Stock | $2.1b | $44.08 | -1.7% | 520.1K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.9b | $36.92 | -1.8% | 882.8K |
 ZYME | Zymeworks Inc. | $1.8b | $28.55 | +1.6% | 950.2K |
 RLAY | Relay Therapeutics, Inc. Common Stock | $1.7b | $14.94 | -1.3% | 4.1M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $1.5b | $16.49 | -1.1% | 615.6K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.5b | $3.49 | -0.6% | 10.9M |
 OGN | Organon & Co. | $1.5b | $13.16 | +16.9% | 134.3M |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.5b | $12.47 | -2.6% | 258.4K |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $1.4b | $14.28 | -0.9% | 1.3M |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.2b | $19.32 | -2.4% | 598.3K |
 HROW | Harrow, Inc. Common Stock | $1.2b | $41.46 | +4.4% | 638.5K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $22.45 | -0.9% | 292.7K |
 ALVO | Alvotech Ordinary Shares | $1.0b | $3.30 | -2.4% | 413.1K |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.0b | $4.17 | +0.5% | 11.9M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $0.9b | $25.54 | +4.2% | 490.6K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $0.9b | $1.78 | -64.6% | 158.5M |
 CERT | Certara, Inc. Common Stock | $0.9b | $6.25 | -1.2% | 2.1M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $0.9b | $131.07 | +1.6% | 780.8K |
 OPK | Opko Health Inc. | $0.8b | $1.21 | -2.0% | 1.4M |
 PHAT | Phathom Pharmaceuticals, Inc. Common Stock | $0.8b | $11.60 | -0.9% | 1.2M |
 FTRE | Fortrea Holdings Inc. Common Stock | $0.8b | $10.60 | +8.2% | 1.8M |
 SDGR | Schrodinger, Inc. Common Stock | $0.8b | $11.74 | -0.4% | 1.8M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.7b | $4.89 | +9.6% | 6.5M |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $3.26 | -0.9% | 2.9M |
 ARVN | Arvinas, Inc | $0.7b | $10.30 | -1.3% | 425.3K |
 VOR | Vor Biopharma Inc. Common Stock | $0.6b | $14.14 | +2.4% | 1.1M |